Skip to main content

Table 2 Distribution of local-regional recurrences by constructed molecular subtype

From: Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy

  HR+/HER2-
N= 309
HR+/HER2+
N= 51
HR-/HER2+
N= 42
HR-/HER2-
N= 193
Local 4 2 4 14
Regional 4 1 1 5